SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,849 | -20.9% | 173,140 | +71.4% | 0.00% | – |
| Q2 2023 | $131,342 | -71.1% | 101,032 | -60.9% | 0.00% | -100.0% |
| Q1 2023 | $455,256 | -5.2% | 258,668 | +69.2% | 0.00% | 0.0% |
| Q4 2022 | $480,169 | -100.0% | 152,920 | -22.1% | 0.00% | -50.0% |
| Q3 2022 | $962,022,000 | +618.9% | 196,331 | +507.4% | 0.00% | – |
| Q2 2022 | $133,826,000 | -37.7% | 32,325 | -12.6% | 0.00% | – |
| Q1 2022 | $214,802,000 | +17.0% | 36,971 | +51.1% | 0.00% | – |
| Q4 2021 | $183,570,000 | -4.6% | 24,476 | +14.6% | 0.00% | – |
| Q3 2021 | $192,454,000 | +154.7% | 21,360 | +238.4% | 0.00% | – |
| Q2 2021 | $75,555,000 | -79.5% | 6,312 | -78.5% | 0.00% | -100.0% |
| Q1 2021 | $368,633,000 | +17.2% | 29,420 | +45.9% | 0.00% | 0.0% |
| Q4 2020 | $314,628,000 | +23.2% | 20,162 | -25.4% | 0.00% | – |
| Q3 2020 | $255,348,000 | +79.7% | 27,021 | +70.4% | 0.00% | – |
| Q2 2020 | $142,097,000 | -62.7% | 15,859 | -73.5% | 0.00% | -100.0% |
| Q1 2020 | $380,697,000 | -88.6% | 59,764 | -85.0% | 0.00% | -83.3% |
| Q4 2019 | $3,327,569,000 | +1831.4% | 397,559 | +1988.3% | 0.01% | – |
| Q3 2019 | $172,285,000 | +29.3% | 19,037 | +53.8% | 0.00% | – |
| Q2 2019 | $133,290,000 | -36.9% | 12,376 | -44.1% | 0.00% | – |
| Q1 2019 | $211,378,000 | +1600.1% | 22,157 | +1945.9% | 0.00% | – |
| Q4 2018 | $12,433,000 | -84.0% | 1,083 | -76.4% | 0.00% | – |
| Q3 2018 | $77,936,000 | -39.4% | 4,598 | -49.3% | 0.00% | – |
| Q2 2018 | $128,680,000 | -92.8% | 9,062 | -90.4% | 0.00% | -100.0% |
| Q1 2018 | $1,785,240,000 | +62.3% | 93,960 | +40.1% | 0.00% | +200.0% |
| Q4 2017 | $1,099,702,000 | +800.7% | 67,055 | +723.8% | 0.00% | – |
| Q3 2017 | $122,100,000 | +77.1% | 8,140 | +3.9% | 0.00% | – |
| Q2 2017 | $68,957,000 | +2820.7% | 7,836 | +1626.0% | 0.00% | – |
| Q1 2017 | $2,361,000 | -36.2% | 454 | -62.6% | 0.00% | – |
| Q4 2016 | $3,700,000 | -83.3% | 1,213 | -74.7% | 0.00% | – |
| Q3 2016 | $22,182,000 | +40.5% | 4,791 | +75.7% | 0.00% | – |
| Q2 2016 | $15,789,000 | -88.1% | 2,727 | -81.2% | 0.00% | – |
| Q4 2015 | $132,202,000 | +64.4% | 14,480 | +1.5% | 0.00% | – |
| Q3 2015 | $80,426,000 | +25.3% | 14,260 | +146.4% | 0.00% | – |
| Q2 2015 | $64,189,000 | +154.4% | 5,788 | +259.7% | 0.00% | – |
| Q1 2015 | $25,229,000 | -42.2% | 1,609 | -60.3% | 0.00% | – |
| Q3 2014 | $43,670,000 | +959.2% | 4,051 | +1400.4% | 0.00% | – |
| Q2 2014 | $4,123,000 | -62.4% | 270 | -65.8% | 0.00% | – |
| Q4 2013 | $10,973,000 | -93.6% | 790 | -95.2% | 0.00% | – |
| Q3 2013 | $171,176,000 | +17.0% | 16,318 | -12.9% | 0.00% | – |
| Q2 2013 | $146,352,000 | – | 18,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |